TenderDekho Logo
GEM

Procurement Opportunity: Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)

Bid Publish Date

26-Nov-2024, 12:15 pm

Bid End Date

17-Dec-2024, 2:00 pm

Progress

Issue26-Nov-2024, 12:15 pm
Technical16-12-2024 18:08:32
Financial
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

100

Bid Type

Two Packet Bid

Categories 8

Directorate Of Purchase And Stores announces a tender for Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678. 48). Quantity: 100. Submission Deadline: 17-12-2024 14: 00: 00. Last date to apply is approaching fast!

Documents 3

GeM-Bidding-7139410.pdf

Main Document

Other Documents

OTHER

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

Ferrostatin-1, purity of more than 95 percent by HPLC, 25 mg in vial,Erastin, purity of more than 9

Directorate Of Purchase And Stores

MUMBAI, MAHARASHTRA

Posted: 21 February 2025
Closed: 19 March 2025
GEM

CORROCIL-766A (SCALE INHIBITOR) F/RHF# 1,SCACIL-766A(POLYMERIC DISPERSANT) F/RHF# 1,SCACIL-766HA (P

Bokaro Steel Plant

BOKARO, JHARKHAND

Posted: 9 March 2025
Closed: 19 March 2025
GEM

Fluo 4 AM,Saponin 25G,PROTEASE INHIBITOR COCKTAIL,AAPH- 2 2-azobis 2-Methyl propinamidine dihydroch

Indian Council Of Medical Research (icmr)

MUMBAI, MAHARASHTRA

Posted: 26 December 2024
Closed: 17 January 2025
GEM

Fetal Bovine Serum,Bovine serum albumin For Molecular Biology,Dulbecco Modified Eagle Medium DMEM,P

Rajiv Gandhi Centre For Biotechnology (rgcb)

THIRUVANANTHAPURAM, KERALA

Posted: 23 May 2025
Closed: 13 June 2025
GEM

Cyanomethane, HPLC,Sodium sulphate anhydrous,Trifluoroacetic Acid,Monosodium metaperiodate,Recombin

Directorate Of Purchase And Stores

MUMBAI, MAHARASHTRA

Posted: 2 April 2025
Closed: 23 April 2025
GEM

Required Documents

1

Certificate (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria

2

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Technical Results

S.No Seller Item Date Status
1ALLIANZ BIOINNOVATION   Under PMAMake : MEDCHEMEXPRESS Model : HY-B1123 Title : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)16-12-2024 18:08:32Qualified
2GENERAL TRADING CORPORATION   Under PMAMake : Sigma Model : Sigma # A6733 Title : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)27-11-2024 09:49:51Qualified
3OTTO CHEMIE PRIVATE LIMITED   Under PMAMake : OTTOKEMI Model : A 3305 Title : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)07-12-2024 18:27:01Qualified
4PROFESSIONAL INDUSTRIAL ENGINEERING CO   Under PMAMake : NA Model : Cat.No. A6733 Title : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)10-12-2024 17:22:19Qualified
5RENWIK BIOINNOVATIONS PRIVATE LIMITED   Under PMAMake : As per Technical Specification Model : NA Title : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)27-11-2024 13:48:36Qualified
6VEDANT ENTERPRISES   Under PMAMake : abcam Model : Cat. No. ab141509 ...AS PER ATTACHED CAT. ONLY. Title : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)16-12-2024 17:27:09Qualified

Financial Results

Rank Seller Price Item
L1ALLIANZ BIOINNOVATION   Under PMA₹27,560Item Categories : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)
L2OTTO CHEMIE PRIVATE LIMITED   Under PMA₹41,418Item Categories : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)
L3RENWIK BIOINNOVATIONS PRIVATE LIMITED   Under PMA₹43,300Item Categories : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)
L4VEDANT ENTERPRISES   Under PMA₹50,000Item Categories : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)
L5GENERAL TRADING CORPORATION   Under PMA₹1,17,900Item Categories : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)
L6PROFESSIONAL INDUSTRIAL ENGINEERING CO   Under PMA₹1,95,880Item Categories : Auranofin (> 98% HPLC, leukocyte activation pathway inhibitor; C20H34AuO9PS, Mol Wt. 678.48)

Frequently Asked Questions

## FAQs
What are the eligibility requirements for **GEM/2024/B/5608805**?

The eligibility requirements include being a registered entity with a valid business license. Bidders must also provide documentation to support any exemption requests from experience or turnover criteria. This ensures that even smaller firms can compete effectively.

What certificates are required for submission?

Bidders are required to submit a certificate as per the Additional Terms and Conditions (ATC). This document must validate that the bidder meets the technical and quality requirements specified in the tender documentation.

How can I register for participation in the tendering process?

Participants can register through the GeM (Government e-Marketplace) portal. A comprehensive guide is available on the portal that details the registration process, required documentation, and verification steps to ensure compliance with government norms.

What document formats are accepted for submission?

All submissions must be made electronically and in formats specified by the GeM portal, typically adhering to PDF or other digitally verifiable formats to ensure authenticity and compliance.

What are the technical specifications for Auranofin?

Auranofin must have a purity greater than 98% HPLC and comply with the chemical specifications of C20H34AuO9PS with a molecular weight of 678.48. Detailed specifications and the quality assurance standards can be found in the linked documentation.

Are there specific quality standards that must be adhered to?

Yes, the tender requires adherence to industry-specific quality standards relevant to the chemical supply sector, ensuring the product's efficacy for research and development purposes.

What compliance requirements are expected from the bidders?

Bidders must comply with the procurement policies outlined in the tender, including adherence to quality standards and providing necessary documentation to demonstrate compliance with the technical specifications.

What are the testing criteria for the delivered product?

The testing criteria include verifying the purity and quality of Auranofin as per the specifications outlined in the tender documents. Compliance with these criteria will be evaluated prior to final acceptance of the delivered product.

What is the Earnest Money Deposit (EMD) for this tender?

The EMD details should be specified in the tender documentation. It serves as a security deposit which bidders must submit to demonstrate their commitment to the bidding process.

Is a performance security required for this tender?

Yes, bidders may be required to submit a performance security deposit post-award to ensure compliance with the contract terms and conditions stated in the tender.

What are the payment terms associated with this tender?

Payment terms generally include advance payments, milestone payments, or payments upon delivery, as specified in the tender documentation. Bidders should review this information closely for compliance.

How will price evaluations be considered in this tender?

Price evaluation will be based on the total value submitted by bidders, taking into account both technical specifications and pricing to determine the most competitive offer.

What submission methods are allowed throughout the tendering process?

Submissions must be conducted electronically via the GeM portal, ensuring that bidders adhere to the prescribed documentation and format as mandated.

Are there key timelines and deadlines associated with this tender?

While the specific timelines can vary, the important dates such as bid opening and submission deadlines are included within the tender documents accessible on the GeM portal for reference.

How will results be notified after the evaluation process?

The results following the evaluation process will be communicated through the GeM portal. Successful bidders will receive notifications detailing the outcome and further instructions.

What benefits do MSEs and startups receive from this tender?

MSEs and startups benefit from exemption provisions regarding experience requirements, facilitating their participation in government tenders. This aligns with the government’s initiative to support local businesses and spur growth.